InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.37
(
-0.63%
)
Bitcoin
58,384.39
(
-2.96%
)
Post# of 49003
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

NeutrinoKid

Send PM Follow Ignore
Followers 6
Posts 134
Boards Moderated 0
Alias Born 01/19/2024

NeutrinoKid

Re: None

Thursday, 05/02/2024 5:14:53 PM

Thursday, May 02, 2024 5:14:53 PM

Post# of 49003
More press.

Mild Cognitive Impairment Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | FUJIFILM Toyama Chemical Co. Ltd., Aptinyx, AgeneBio, Eisai Inc., RespireRx, Allon Therapeutics, CuraSen Therapeutics
05-02-2024 08:01 PM CET | Health & Medicine
Press release from: DelveInsight Business Research

“• Key Mild Cognitive Impairment Companies: FUJIFILM Toyama Chemical Co. Ltd., Aptinyx, AgeneBio, Eisai Inc., RespireRx, Allon Therapeutics, CuraSen Therapeutics, Inc., Avraham Pharma, AstraZeneca, Sage Therapeutics, Pfizer, Materia Medica Holding, Eli Lilly and Company, GE Healthcare, Parexel, and others
• Key Mild Cognitive Impairment Therapies: T-817MA, NYX-458, Aptinyx, T-817MA, Aricept (donepezil hydrochloride), CX516, AL-208, CST-2032, ladostigil hemitartrate, AZD5213, SAGE-718, fesoterodine, MMH-MAP, Donanemab, Flutemetamol (18F) Injection, EVP-0962, and others “

“Mild Cognitive Impairment Therapies and Key Companies
• T-817MA: FUJIFILM Toyama Chemical Co. Ltd.
• NYX-458: Aptinyx
• Aptinyx: AgeneBio
• T-817MA: FUJIFILM Toyama Chemical Co., Ltd.
• Aricept (donepezil hydrochloride): Eisai Inc.
• CX516: RespireRx
• AL-208: Allon Therapeutics
• CST-2032: CuraSen Therapeutics, Inc.
• ladostigil hemitartrate: Avraham Pharma
• AZD5213: AstraZeneca
• SAGE-718: Sage Therapeutics
• fesoterodine: Pfizer
• MMH-MAP: Materia Medica Holding
• Donanemab: Eli Lilly and Company
• Flutemetamol (18F) Injection: GE Healthcare
• EVP-0962: Parexel“

https://www.openpr.com/news/3483246/mild-cognitive-impairment-market-to-observe-impressive-growth
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RSPI News
More RSPI News
InvestorsHub NewsWire

FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!